Variable | Level | Events | Total | Univariate model | Multivariate model | ||||
---|---|---|---|---|---|---|---|---|---|
HR | 95%CI | p | HR | 95%CI | p | ||||
PABC | Yes | 13 | 63 | 2.925 | 1.277 ~ 6.701 | 0.011 | 1.230 | 0.460 ~ 3.290 | 0.681 |
No | 10 | 126 | 1 | Â | Â | Â | Â | Â | |
Age at diagnosis |  ≤ 35 | 16 | 133 | 1.009 | 0.414 ~ 2.456 | 0.985 |  |  |  |
 > 35 | 7 | 56 | 1 |  |  |  |  |  | |
Family history | Yes | 4 | 18 | 2.222 | 0.747 ~ 6.615 | 0.151 | 2.113 | 0.555 ~ 8.049 | 0.273 |
No | 19 | 171 | 1 | Â | Â | Â | Â | Â | |
TNM stage | III/IV | 18 | 48 | 15.741 | 5.810 ~ 42.646 |  < 0.001 | 30.875 | 7.232 ~ 131.820 |  < 0.001 |
0/I/II | 5 | 141 | 1 | Â | Â | Â | Â | Â | |
ER |  +  | 12 | 120 | 0.543 | 0.240 ~ 1.233 | 0.144 | 1766.341 | 0.000 ~ 3.509*107 | 0.931 |
- | 11 | 69 | 1 | Â | Â | Â | Â | Â | |
PR |  +  | 10 | 108 | 0.530 | 0.231 ~ 1.216 | 0.134 | 1.111 | 0.174 ~ 7.081 | 0.912 |
- | 13 | 81 | 1 | Â | Â | Â | Â | Â | |
HR |  +  | 12 | 124 | 0.494 | 0.218 ~ 1.211 | 0.092 | 0.000 | 0.000 ~ 3.365*106 | 0.920 |
- | 11 | 65 | 1 | Â | Â | Â | Â | Â | |
Her-2 |  +  | 17 | 120 | 1.842 | 0.725 ~ 4.683 | 0.199 | 2.844 | 0.845 ~ 9.565 | 0.091 |
- | 6 | 69 | 1 | Â | Â | Â | Â | Â | |
Ki-67 |  ≥ 14% | 19 | 149 | 1.813 | 0.612 ~ 5.371 | 0.283 |  |  |  |
 < 14% | 4 | 40 | 1 |  |  |  |  |  | |
Breast surgery | BMS | 19 | 156 | 1.317 | 0.440 ~ 3.938 | 0.622 |  |  |  |
CMS | 4 | 33 | Â | Â | Â | Â | Â | Â | |
Chemotherapy | No | 1 | 9 | 1 | Â | Â | Â | Â | Â |
ACT | 13 | 142 | 0.529 | 0.068 ~ 4.089 | 0.542 |  |  |  | |
NACT + ACT | 9 | 38 | 2.141 | 0.270 ~ 16.958 | 0.471 |  |  |  | |
Radiotherapy | Yes | 18 | 101 | 3.289 | 1.219 ~ 8.874 | 0.019 | 1.105 | 0.356 ~ 3.434 | 0.865 |
No | 5 | 88 | 1 | Â | Â | Â | Â | Â | |
Endocrine therapy | Yes | 4 | 106 | 0.134 | 0.045 ~ 0.394 |  < 0.001 | 0.200 | 0.049 ~ 0.818 | 0.025 |
No | 19 | 83 | 1 | Â | Â | Â | Â | Â | |
Targeted therapy | Yes | 2 | 46 | 0.356 | 0.083 ~ 1.520 | 0.163 | 0.143 | 0.028 ~ 0.743 | 0.021 |
No | 21 | 143 | 1 | Â | Â | Â | Â | Â |